188 EAST BLAINE STREET, SUITE 400, SEATTLE, WA
Market cap: $1.1B (2/08/2026)
Price: $4.00
Investor Presentation
Reports Third Quarter 2025 Financial Results and Business Updates
Material disclosure
Changes in Board, Management or Compensation
Reports Second Quarter 2025 Financial Results and Business Updates
Announces Pricing of Public Offering
Earnings Release
Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement
Free Writing Prospectus
Amended Notice of Proposed Sale of Securities